Immunotherapy for the treatment of AMD: a preclinical evaluation
Age-related Macular Degeneration (AMD) is the leading cause of central retinal vision loss worldwide. Estimated prevalence of AMD in Ireland is 7% with an annual cost
- Award Date
- 23 October 2015
- Award Value
- €32,500
- Principal Investigator
- Dr Sarah Doyle
- Host Institution
- Trinity College Dublin
- Scheme
- Knowledge Exchange and Dissemination Scheme